Jump to content
RemedySpot.com

RE: Has anyone heard of this clinical trial

Rate this topic


Recommended Posts

Guest guest
Posted

Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-938

in Patients with Chronic Hepatitis C

-- PSI-938 single ascending dose study in healthy volunteers supports

progression to 7 day monotherapy study in HCV infected patients

-- PSI-938 was generally safe and well tolerated with no dose-limiting toxicity

-- Further results from single ascending and multiple ascending dose trials are

expected in the third quarter 2010

I found this on the business page. Below is the link to the page on the

article.

I was just wondering if this a drug that we would be able to take without

peg/rib combo. I am going to ask my doctor about it.

here is link

http://finance./news/Pharmasset-Initiates-Phase-1b-prnews-539778225.htm\

l?x=0 & .v=1

Thanks

Lois

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...